Director, Health Economics and Outcomes Research (HEOR), Europe

Zug, Switzerland, Switzerland
Feb 21, 2021
Required Education
Masters Degree/MBA
Position Type
Full time

Position Summary:

Global Blood Therapeutics (GBT) is a biopharmaceutical company dedicated to the discovery, development and delivery of life-changing treatments that provide hope to underserved patient communities. Founded in 2011, GBT is delivering on its goal to transform the treatment and care of sickle cell disease (SCD), a lifelong, devastating inherited blood disorder. The company has introduced Oxbryta® (voxelotor), the first FDA-approved treatment that directly inhibits sickle hemoglobin polymerization, an underlying cause of SCD. GBT is also advancing its pipeline program in SCD with inclacumab, a p-selectin inhibitor in development to address pain crises associated with the disease. In addition, GBT's drug discovery teams are working on new targets to develop the next generation of treatments for SCD. We are currently expanding our geographic footprint to Europe. To learn more, please visit and follow the company on Twitter @GBT_news.

This Zug-based position will be a pro-active scientific contributor and member for the global medical affairs Team, providing Health Economic Outcome Research (HEOR) expertise. This position will partner with Access roles in Europe as well as the US, with European commercial and medical affairs teams to deliver high quality HEOR research in support of GBT product market access activities in European countries.

The position reports in direct line to the Senior Director Health Economics and Outcomes Research and in dotted line to the VP Market Access Europe.

Essential Duties and Responsibilities:

  • Being a member of the Market Access and External Relations Team Europe, which is responsible for all access and external relations aspects within GBT Europe

HEOR Deliverables

  • In alignment with global plans lead development of HEOR's European annual and longer-range vision, strategy, plans, and goals
  • Lead strategic planning efforts for prioritized product portfolio and/or geographies to ensure that HEOR programs deliver meaningful, robust and competitive data that meet the current and future needs of key stakeholders. (national / regional HTA, HCP)
  • Work with regional / local access and medical leads in key countries to determine evidence needs and guide strategic direction of development teams to define and execute consistent and compelling product value strategies
  • Develop, implement and deliver post-launch payer and marketing focused evidence plans to support uptake and adoption
  • Lead, design and oversee the conduct of scientific research to support value propositions of marketed and pipeline acute care products to meet high quality objectives
  • Oversee all aspects of European HEOR scientific strategy and provide strategic consultation regarding methods and standards
  • Develop and deliver Global Value Dossier for effective use by countries in gaining access for key products. Support designated country Health Technology Assessments/ reimbursement, and funding submissions
  • Ensure the delivery of required economic models (CEA, BIA) and stakeholder engagement tools to effectively communicate the benefit of GBT therapies to patients, providers and payers
  • Provide senior leadership with a working knowledge of HEOR and Market Access needs. Drives training on key HEOR themes
  • Maintain strategic external perspective and stays abreast of external developments that affect the HEOR domain
  • Oversee and manage strong research partnerships with academic research institutions, customers, contract research organizations


  • Ensure all activities and plans are executed in alignment with GBT high ethics and compliance standards as well as with local laws and regulations


  • Masters or advanced degree in Health Economics, epidemiology, health services research, biostatistics, public health, or other relevant field for HE&OR
  • +10 years HEOR in or for the pharmaceutical industry
  • Content expertise in the design, conduct and implementation of clinical outcomes trials, observational studies (incl. retrospective studies) phase II-IV
  • Demonstrated history of developing impactful HEOR strategies to meet European payer and HTA evidence needs
  • Expert experience in tactical application of health economics & outcomes research and information at the disease and product level
  • Good analytical skills as applied to health economic modeling, observational research and patient-reported outcomes research
  • Demonstrated ability to accurately and effectively follow and draw conclusions from latest development and outcomes of market access efforts within Europe
  • Start-up and negotiation experience are a plus
  • Fluency in English required, other European language(s) are a plus

Fit with GBT culture:

  • Ability to build strong relationships with co-workers of various backgrounds and expertise
  • Ability to function at a high level in a team setting whether leading the group or acting as an individual contributor
  • Values-based leadership consistent with GBT's Core Values
  • Excitement about the vision and mission of GBT
  • Flexibility
  • Integrity

NOTE: This position summary is not intended to be all-inclusive. Employee may perform other related duties as negotiated to meet the ongoing needs of the organization.

Global Blood Therapeutics is an equal opportunity employer, and all qualified applicants will receive consideration for employment without regard to age, race, color, religion, sex, sexual orientation, gender identity, national origin, protected veteran status, or disability status, or any other characteristic protected by law.